Robert Harper

Principal investigator.

Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$12.8MFederal grants as PI20 awards
2Patents grantedLatest Jun 22, 2021
0PapersOpenAlex
Career record

Federal awards and patents by year

20172026
AwardsPatents
Federal awards as principal investigator

20 awards · $12.8M

DateAgencyAwardAmountCompany
Sep 10, 2026NIHSBIR Phase I
A Point of Care-Device for the Determination of Blood Tyrosine (TYR) the "TYR Now"
$312KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Sep 2, 2026NIHSBIR Phase II
A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now
$1.1MANALYTICAL DIAGNOSTIC SOLUTIONS INC
Aug 5, 2026NIHSBIR Phase I
A Point of Care Device for Patients with Oxalurias, the Oxalate Now
$311KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Sep 22, 2025NIHSBIR Phase II
A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now
$906KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Jun 27, 2025NIHSBIR Phase I
A point-of-care device for the determination of homocysteine (Hcy), the Hcy Now
$305KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Sep 20, 2023NIHSBIR Phase I
A point of care-device for the determination of creatinine phosphokinase (CPK), the CPK Now
$296KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Sep 19, 2023NIHSBIR Phase I
PKU Now-Connect: An intelligent digital ecosystem to improve health outcomes in Phenylketonuria
$291KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Aug 18, 2023NIHSBIR Phase I
ADA2 Diagnostic Platform: Point-of-care test for determination of patient enzyme levels for diagnosis of the rare disease Deaminase2 Deficiency (DADA2)
$300KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Sep 1, 2021NIHSBIR Phase II
PreQuine Platform. A novel point of care device for the diagnosis andmonitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)
$2.9MANALYTICAL DIAGNOSTIC SOLUTIONS INC
Aug 3, 2021NIHSBIR Phase II
A point-of-care device for phenylalanine determination
$1.0MANALYTICAL DIAGNOSTIC SOLUTIONS INC
Jul 6, 2020NIHSBIR Phase II
A point-of-care device for phenylalanine determination
$945KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Apr 1, 2020NIHSBIR Phase II
A user-friendly point-of-care device for G6PDH determination
$574KANALYTICAL DIAGNOSTIC SOLUTIONS INC
May 1, 2019NIHSBIR Phase II
A user-friendly point-of-care device for G6PDH determination
$1.4MANALYTICAL DIAGNOSTIC SOLUTIONS INC
Apr 29, 2019NIHSBIR Phase II
A user-friendly point-of-care device for G6PDH determination
$873KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Apr 12, 2018NIHSBIR Phase I
A point-of-care device for the determination of the Bilirubin, the BiliNow
$225KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Mar 26, 2018NIHSBIR Phase I
A point-of-care device for phenylalanine determination
$225KANALYTICAL DIAGNOSTIC SOLUTIONS INC
2018NSFSBIR Phase I
SBIR Phase I: A user-friendly point-of-care device for simultaneous G6PDH and hemoglobin determination
$225KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Dec 18, 2017NSFSBIR Phase I
SBIR Phase I: A user-friendly point-of-care device for simultaneous G6PDH and hemoglobin determination
$225KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Feb 8, 2017NIHSBIR Phase I
A user friendly point of care device for G PDH determination
$191KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Feb 7, 2017NIHSBIR Phase I
A user-friendly point-of-care device for G6PDH determination
$191KANALYTICAL DIAGNOSTIC SOLUTIONS INC
Patents

3 patents as inventor

Matched by the first inventor’s name and the patent’s company.

Among 4,795 researchers in Medtech

Peer ranks

Federal funding#38
Awards as PI#27
Patents#185
From filings, awards and patents

Companies

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.